Cited by 157DNA Repair MechanismsCancer-related Molecular PathwaysBRCA gene mutations in cancer

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation

Open access
Lin, Shiaw-Yih, Li, Kaiyi, Stewart, Grant S., Elledge, Stephen J.·2004·Proceedings of the National Academy of Sciences

Abstract

Claspin is a homolog of Mrc1, a checkpoint protein required for the DNA replication checkpoint in yeast. In Xenopus , phosphorylated Claspin binds to xChk1 and regulates xChk1 activation in response to replication stress. In this study, we have shown that the human homolog of Claspin is required for resistance to multiple forms of genotoxic stress including UV, IR, and hydroxyurea. Phosphorylation of Claspin was found to depend on the ataxia telangiectasia mutated-Rad3 related (ATR) pathway. DNA damage induces the formation of a complex between Claspin and BRCA1, a second regulator of Chk1 activation. Claspin was found to control BRCA1 phosphorylation on serine 1524, a site whose phosphorylation is controlled by the ATR pathway. These results are consistent with a model in which ATR regulates Claspin phosphorylation in response to DNA damage and replication stress resulting in recruitment and phosphorylation of BRCA1. BRCA1 and Claspin then function to activate the tumor suppressor Chk1. Unexpectedly, we found that Claspin has a second, positive role in control of the cell cycle as Claspin overexpression increased cell proliferation. These results suggest that Claspin has properties of both a tumor suppressor and an oncogene.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0401847101

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 27 references

Cited by

Sorted by citations

Items 101–157 of 157

Metadata

Authors
Lin, S.-Y., Li, K., Stewart, G. S., & Elledge, S. J.
Affiliations
Howard Hughes Medical Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
2004-04-19
Volume
101
Issue
17
Pages
6484-6489
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2129258256
Cited by
156
References
27
Citations by year
2026: 1 · 2025: 4 · 2024: 11 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 6 · 2013: 3 · 2012: 7
FWCI
5.33
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Institutes of Health
  • National Cancer Institute (F32CA093043)
  • National Institute of General Medical Sciences (GM-44664, R37GM044664, R01GM044664)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Keywords
Claspin, BRCA1, Chk1, ATR pathway, DNA damage response, genotoxic stress resistance, replication stress, cell proliferation, tumor suppressor, oncogenes, protein phosphorylation, hydroxyurea
MeSH terms
Base Sequence, Carrier Proteins, Cell Division, Cell Survival, DNA Damage, Humans, Oligoribonucleotides, Phosphorylation, Protein Binding, BRCA1 Protein, Xenopus Proteins, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review